Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex shares drop 11% on CF drug study
Vertex shares drop 11% on CF drug study
Vertex shares drop 11% on CF drug study
Submitted by
admin
on June 28, 2012 - 12:52pm
Source:
Marketwatch
News Tags:
Vertex Pharmaceuticals
cystic fibrosis
VX-809
Headline:
Vertex shares drop 11% on CF drug study
Do Not Allow Advertisers to Use My Personal information
